---
$id: https://graph.org.ai/products/commodity/51204101
$type: Product
source: UNSPSC
code: "51204101"
title: "Alefacept"
class: "51204100"
classTitle: "Immunosupressant recombinant fusion proteins"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Alefacept

**UNSPSC Code**: 51204101
**Class**: [Immunosupressant recombinant fusion proteins](Immunosupressant recombinant fusion proteins.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an immunosuppressant with the molecular formula C2306H3594N610O694S26, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) ELK3V90G6C, more generally known as alefacept. European Medicines Agency schedules alefacept in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20562. The term ALEFACEPT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 no. 3-4, 2001, list 46). Most nations, for tariff and trade purposes, schedule alefacept under HS 30021095 and SITC 54163 (for the most current information on WCO designations on alefacept and salts thereof, please see Committee proceedings HSC/37, NC1059B2b Ann. O/3, 2006). As of Q4 2014, ALEFACEPT remains US FDA's Preferred Term for this commodity. Alefacept bears US NLM identifiers UMLS ID C0962603 and NCI Concept Code C65220. SMILES: C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)CL.

